Abortion care (QS199)
This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.
Search results
335 results
-
-
Venous thromboembolism in adults: diagnosis and management (QS29)
This quality standard covers diagnosing and treating venous thromboembolism (VTE) in adults. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It describes high-quality care in priority areas for improvement.
-
Suspected neurological conditions: recognition and referral (QS198)
This quality standard covers assessing and referring children (under 16) and adults (16 and over) who have symptoms or signs associated with neurological conditions. It describes high-quality care in priority areas for improvement.
-
Community pharmacies: promoting health and wellbeing (QS196)
This quality standard covers how community pharmacies can support the health and wellbeing of the local population. It describes high-quality care in priority areas for improvement.
-
Faltering growth (QS197)
This quality standard covers recognising and managing faltering growth in babies (aged up to 1 year) and preschool children (aged over 1 year). It describes high-quality care in priority areas for improvement.
-
Heavy menstrual bleeding (QS47)
This quality standard covers assessing and managing heavy menstrual bleeding (menorrhagia), including suspected or confirmed fibroids and adenomyosis. It describes high-quality care in priority areas for improvement.
-
Acute coronary syndromes in adults (QS68)
This quality standard covers diagnosing and managing acute coronary syndromes in adults (aged 18 and over). Acute coronary syndromes are medical emergencies that include myocardial infarction (heart attack) and unstable angina (unexpected, severe chest pain). It describes high-quality care in priority areas for improvement.
-
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)
Summary of the evidence on antimicrobial prescribing: delafloxacin
-
Antimicrobial prescribing: cefiderocol (ES31)
Summary of the evidence on antimicrobial prescribing: cefiderocol
-
COVID-19 rapid evidence summary: Sarilumab for COVID-19 (ES34)
ES34 Product overview The content of this evidence summary was up to date in January 2021. New evidence may have been
-
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)
Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam
-
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis (ES35)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
-
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)
ES33 Product overview The content of this evidence summary was up to date in February 2021. New evidence may have been
-
In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA), who have a recorded CVD risk assessment score (using the QRISK2 assessment tool) of more than 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)
In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...
-
The percentage of patients aged 79 years or under with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12 months) is 140/90 mmHg or less
The percentage of patients aged 79 years or under with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12...
-
The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of alcohol consumption in the preceding 15 months
NICE indicators. NM15 schizophrenia guidance.
-
The percentage of patients with diabetes with a record of a foot examination and risk classification: 1) low risk (normal sensation, palpable pulses), 2) increased risk (neuropathy or absent pulses), 3) high risk (neuropathy or absent pulses plus deformity or skin changes or previous ulcer) or 4) ulcerated foot within the preceding 15 months
NICE indicators. NM13 Diabetes foot problems guidance.
-
The percentage of patients with diabetes, on the register, in whom the last blood pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less
NICE indicators. NM01 Diabetes guidance.
-
The proportion of lung cancer cases for which a stage at diagnosis is recorded
The proportion of lung cancer cases for which a stage at diagnosis is recorded Subject(s): Cancer
-
Proportion of pregnant women who were smokers at the time of delivery
Proportion of pregnant women who were smokers at the time of delivery Subject(s): Pregnancy and neonates
-
The proportion of full term births where the child has a low birth weight
The proportion of full term births where the child has a low birth weight Subject(s): Pregnancy and neonates
-
The proportion of births resulting in a neonatal unit admission
The proportion of births resulting in a neonatal unit admission Subject(s): Pregnancy and neonates
-
The proportion of pregnant women having a planned caesarean section who have the procedure carried out at or after 39 weeks 0 days
The proportion of pregnant women having a planned caesarean section who have the procedure carried out at or after 39 weeks 0 days
-
The proportion of babies exclusively or partially breastfed 6 to 8 weeks after birth
The proportion of babies exclusively or partially breastfed 6 to 8 weeks after birth Subject(s): Pregnancy and neonates
-
Proportion of pregnant women who were smokers during pregnancy
Proportion of pregnant women who were smokers during pregnancy Subject(s): Pregnancy and neonates Date of publication:
-
The proportion of people with severe mental illness who are recorded as current smokers
The proportion of people with severe mental illness who are recorded as current smokers Subject(s): Smoking
-
Mortality rates within 30 days of hospital admission for stroke
Mortality rates within 30 days of hospital admission for stroke Subject(s): Stroke and ischaemic attack, Mortality
-
The proportion of people who receive psychological support for mood, behaviour or cognitive disturbance 6 months after an admission to hospital with a stroke
The proportion of people who receive psychological support for mood, behaviour or cognitive disturbance 6 months after an admission to hospital with a
-
Proportion of people with stroke who receive joint health and social care plans on discharge from hospital
Proportion of people with stroke who receive joint health and social care plans on discharge from hospital Subject(s): Stroke and
-
The proportion of people who had a stroke that are supported by a skilled stroke early supported discharge (ESD) team
The proportion of people who had a stroke that are supported by a skilled stroke early supported discharge (ESD) team Subject(s):
-
The percentage of patients newly diagnosed with diabetes, on the register, in the preceding 1 April to 31 March who have a record of being referred to a structured education programme within 9 months after entry on to the diabetes register
NICE indicators. NM27 diabetes guidance
-
The percentage of patients under 80 years old with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 140/90 or less
NICE indicators. NM53 hypertension guidance.
-
The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have been reviewed within 10-35 days of the date of diagnosis
NICE indicators. NM50 depression guidance.
-
The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have had a bio-psychosocial assessment by the point of diagnosis
NICE indicators. NM49 depression guidance.
-
The percentage of people with a new diagnosis of hypertension (diagnosed on or after 1 April 2014) that has been confirmed by ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) in the 3 months before being entered on the register
The percentage of people with a new diagnosis of hypertension (diagnosed on or after 1 April 2014) that has been confirmed by ambulatory blood...
-
The percentage of patients with cancer diagnosed within the preceding 15 months who have a review recorded as occurring within 3 months of the practice receiving confirmation of the diagnosis
The percentage of patients with cancer diagnosed within the preceding 15 months who have a review recorded as occurring within 3 months of the...
-
The percentage of patients with COPD and Medical Research Council (MRC) Dyspnoea Scale of 3 or more at any time in the preceding 15 months, with a subsequent record of an offer of referral to a pulmonary rehabilitation programme
NICE indicators. NM47 COPD guidance.
-
The percentage of patients with hypertension aged 16 to 74 years who score 'less than active' on GPPAQ in the preceding 15 months, who also have a record of a brief intervention in the preceding 15 months
NICE indicators. NM37 physical activity guidance.
-
The percentage of patients with peripheral arterial disease with a record in the preceding 15 months that aspirin or an alternative anti-platelet is being taken
NICE indicators. NM33 peripheral arterial disease guidance.
-
The percentage of patients with rheumatoid arthritis aged 30-84 years who have had a cardiovascular risk assessment using a CVD risk assessment tool adjusted for RA in the preceding 15 months
NICE indicators. NM56 rheumatoid arthritis guidance.
-
The percentage of patients with rheumatoid arthritis who have had a face to face annual review in the preceding 15 months
NICE indicators. NM58 rheumatoid arthritis guidance.
-
The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood pressure in the preceding 15 months
NICE indicators. NM17 schizophrenia guidance.
-
The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of BMI in the preceding 15 months
NICE indicators. NM16 schizophrenia guidance.
-
The percentage of women with diabetes aged 17 or over and who have not attained the age of 45 who have a record of being given information and advice about pregnancy or conception or contraception tailored to their pregnancy and contraceptive intentions recorded in the preceding 12 months
NICE indicators. NM70 diabetes guidance.
-
The practice can produce a register of all patients aged 16 years and over with rheumatoid arthritis
NICE indicators. NM55 rheumatoid arthritis guidance.
-
The percentage of women with epilepsy who are aged 18 or over, but under 45, who are taking anti-epileptic drugs and have a record of being given information and advice in the previous 12 months about pregnancy or conception, or contraception tailored to their pregnancy and contraceptive intentions
NICE indicators. NM71 epilepsy guidance.
-
The contractor establishes and maintains a register of all patients aged 17 or over with diabetes mellitus, which specifies the type of diabetes where a diagnosis has been confirmed
NICE indicators. NM41 diabetes guidance.
-
The contractor establishes and maintains a register of patients: 1. Aged 50 or over and who have not attained the age of 75 with a record of a fragility fracture on or after 1 April 2012 and a diagnosis of osteoporosis confirmed on DXA scan, and 2. Aged 75 or over with a record of a fragility fracture on or after 1 April 2014 and a diagnosis of osteoporosis
NICE indicators. NM29 osteoporosis guidance.
-
The contractor establishes and maintains a register of patients with peripheral arterial disease
The contractor establishes and maintains a register of patients with peripheral arterial disease Subject(s): Peripheral arterial disease
-
The percentage of male patients with diabetes who have a record of erectile dysfunction with a record of advice and assessment of contributory factors and treatment options in the preceding 15 months
NICE indicators. NM52 diabetes guidance.